Skip to main content

Norwood Financial Corp Announces Timing of Fourth Quarter 2025 Earnings Release and Conference Call

HONESDALE, Pa., Jan. 12, 2026 (GLOBE NEWSWIRE) — Norwood Financial Corp (Nasdaq Global Market-NWFL) and its subsidiary, Wayne Bank, will release its fourth quarter 2025 financial results before market opens on Thursday, January 22, 2026. On the same day, the Company will host a webcast and conference call at 9:00 a.m. ET to discuss the financial results. To participate in the live call, you may register and connect via webcast using this link: https://register-conf.media-server.com/register/BId8cb7a4a39794e3d8ff337212d6f4fac. Upon registering, dial-in info and a unique pin to join the call will be provided, as well as an email confirmation with details. A slide presentation will simultaneously be available for download on the Investor Relations website at ir.wayne.bank. A replay of the event, as well as a transcript, can be accessed...

Continue reading

Kraig Biocraft Laboratories Takes Possession of Third Rearing Center, Completing Core Infrastructure Upgrades for 2026 Production Scale-Up

ANN ARBOR, Mich., Jan. 12, 2026 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) (“the Company”, “Kraig Labs”, or “Kraig’s”), a world leader in spider silk technology*, today announced that it has taken possession of its third silkworm rearing center, completing the core physical infrastructure upgrades, underpinning the Company’s massive recombinant spider silk production scale-up planned for 2026. This newest facility represents the final major component of the Company’s multi-year production expansion strategy. With three fully operational rearing centers, Kraig Labs will be able to run three simultaneous production cycles, providing both production diversity and the capacity required to meet and exceed one metric ton of finished spider silk per month. This...

Continue reading

WTW Radar integrates with Databricks to simplify and fast-track data sharing

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW) today announced the launch of the Radar Connector for Databricks, a significant addition to WTW’s market-leading end-to-end insurance analytics and pricing platform. The new integration allows Radar users to connect securely with Databricks – eliminating manual data movement, accelerating analysis and improving governance. The integration between WTW Radar and Databricks enables Radar to access data by selecting Databricks as a data source and to retrieve data straight from the Databricks Data Intelligence Platform in a single step. After completing their analysis, users can directly transfer results back into Databricks. These activities can also be completed as part of automated processes. The Radar Connector for Databricks offers a faster, smoother and more efficient...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – RIO TINTO PLC-SPON ADR – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Rio...

Continue reading

MaxCyte Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Financial Results

ROCKVILLE, Md., Jan. 12, 2026 (GLOBE NEWSWIRE) — MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today provided a preliminary update on financial results for the fourth quarter and full year ended December 31, 2025. Preliminary Unaudited Fourth Quarter and Full Year 2025 ResultsCore revenue in the fourth quarter is expected to be between $6.6 million and $6.7 million. Core revenue for the full year is expected to be between $29.5 million and $29.6 million. Strategic Platform License (SPL) program-related revenue in the fourth quarter is expected to be between $0.4 million and $0.6 million. SPL program-related revenue for the full year is expected to be...

Continue reading

CompoSecure Completes Business Combination with Husky Technologies and Rebrands Corporate Entity to GPGI, Inc.

Completed business combination with Husky Technologies creating a $7.4 billion best-in-class, diversified compounder Rebrands corporate entity to GPGI, Inc. (“Great Positions in Good Industries”) with two reporting segments CompoSecure and HuskyCompleted Business Combination SOMERSET, N.J., Jan. 12, 2026 (GLOBE NEWSWIRE) — CompoSecure, Inc. (NYSE: CMPO) completed its previously announced business combination with Husky Technologies Limited (“Husky”), a leader in highly engineered equipment and aftermarket services. The combination of Husky and CompoSecure creates a best-in-class, diversified compounder featuring two global market leaders with ~70% recurring revenues, high margins, and strong free cash flow generation. As previously disclosed, the combined business is valued at $7.4 billion1, representing ~11.6x 2026E Pro Forma...

Continue reading

Dimensional Fund Advisors Ltd. : Form 8.3 – RIO TINTO LTD – Ordinary Shares

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION     (a) Full name of discloser: Dimensional Fund Advisors Ltd. in its capacity as investment advisor and on behalf its affiliates who are also investment advisors (”Dimensional”). Dimensional expressly disclaims beneficial ownership of the shares described in this form 8.3.  (b) Owner or controller of interests and short positions disclosed, if different from 1(a):The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.    (c) Name of offeror/offeree in relation to whose relevant securities this form relates:Use a separate form for each offeror/offeree Rio...

Continue reading

Schouw & Co. share buy-back programme, week 1+2 2026

On 2 January 2026, Schouw & Co. initiated a share buy-back programme as outlined in Company Announcement no. 59 of 18 December 2025. Under the programme, Schouw & Co. will acquire shares for up to DKK 240 million during the period 2 January to 31 December 2026. The buy-back will be structured in accordance with Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR) and the Commission’s delegated regulation (EU) 2016/1052 of 8 March 2016 (“Safe Harbour” rules).Trading day No. of shares Average price DKK AmountDKK    Friday, 2 January 2026 1,500 661.65 992,470    Monday, 5 January 2026 3,000 665.00 1,995,000    Tuesday, 6 January 2026 1,500 669.00 1,003,500    Wednesday, 7 January 2026 3,000 675.00 2,025,000    Thursday, 8 January 2026 3,000 675.00 2,025,000    Friday,...

Continue reading

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences

MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences IRVINE, CA – January 12, 2026 (GlobeNewswire) – MDxHealth SA (NASDAQ: MDXH) (the “Company” or “mdxhealth”), a leading precision diagnostics company, today reported preliminary fourth quarter and full year 2025 revenues and issued 2026 revenue guidance. The Company expects to report fourth quarter and full year 2025 revenues of approximately $30.5 million and $109 million, respectively, representing year-over-year growth of 23% and 21%, respectively. During the fourth quarter, the Company billed 11,201 tissue-based units and 27,486 liquid-based units, representing year-over-year growth of (5%) and 128%, respectively, reflecting Q4 focus on integration of the Exosome...

Continue reading

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance 36% to 38% Annual YoY HIFU Revenue Growth, Record Performance Driven by Increased Focal One® System Sales and Growth in Number of U.S. Focal One Procedures 69% Annual YoY Growth in Focal One System Placements 28% Q4 YoY Growth in U.S. Procedures Highlights Accelerating Quarterly Procedure Growth AUSTIN, Texas, January 12, 2026 — EDAP TMS SA (Nasdaq: EDAP) (“the Company” or “EDAP”), the global leader in robotic energy-based therapies, today announced select preliminary unaudited financial and operational results highlighting record fourth quarter and full-year 2025 HIFU revenue, driven by strong system placements and accelerating procedure growth. The Company also issued initial worldwide revenue guidance for 2026. For the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.